Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature-Reference-Cited by-同舟云学术

Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature

Published:2022-10 Issue: Volume:168 Page:150-155
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Benidir Tarik^ORCID,Hofmann Martin,Lone Zaeem^ORCID,Nguyen Jane K.,Purysko Andrei S.,Stovsky Mark,Klein Eric A.,Weight Christopher J.

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Early detection of prostate cancer: AUA guideline;Carter;J Urol,2013

2. Aberrant PSA glycosylation—a sweet predictor of prostate cancer;Gilgunn;Nat Rev Urol,2013

3. Interlaboratory Study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012;Leymarie;Mol Cell Proteomics,2013

4. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia;Saldova;Glycobiology,2011

5. Glycosylation of prostate specific antigen and its potential diagnostic applications;Vermassen;Clin Chim Acta,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of Solvent Interaction Analysis Signatures with Thermodynamic Properties and In Silico Calculations of the Structural Effects of Point Mutations in Two Proteins;International Journal of Molecular Sciences;2024-09-06

2. Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study;Urologic Oncology: Seminars and Original Investigations;2022-09